Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL/6N mice

Chemico-Biological Interactions

Volumn 186, Issue 3, 2010, Pages 316-322

  Woo, Myoung Nam ^a   Jeon, Seon Min ^a   Kim, Hye Jin ^b   Lee, Mi Kyung ^c   Shin, Su Kyung ^a   Shin, Young Chul ^d   Park, Yong Bok ^a   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b CJ Corporation   (South Korea)

^c Sunchon National University   (South Korea)

^d Amicogen Inc   (South Korea)

Author keywords

Blood glucose level; Fucoxanthin; Lipid profiles; PPARs

Indexed keywords

ACYL COENZYME A OXIDASE; CHOLESTEROL ACYLTRANSFERASE; FATTY ACID SYNTHASE; FUCOXANTHIN; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INSULIN; LIPID; LIVER ENZYME; MALATE DEHYDROGENASE (DECARBOXYLATING); MESSENGER RNA; PALMITOYL ACYL COENZYME A OXIDASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDATE PHOSPHATASE; RESISTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FATTY ACID OXIDATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ALGAE, BROWN; ANIMALS; BLOOD GLUCOSE; DIETARY FATS; DIETARY SUPPLEMENTS; EATING; GLUCAGON; HEMOGLOBIN A; INSULIN; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; PLANT EXTRACTS; RNA, MESSENGER; WEIGHT GAIN; XANTHOPHYLLS;

MUS;

EID: 77954385541     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.05.006     Document Type: Article

References (42)

1. Sheng L., Qian Z., Shi Y., Yang L., Xi L., Zhao B., Xu X., Ji H. Crocetin improves the insulin resistance induced by high-fat diet in rats. Br. J. Pharmacol. 2008, 154:1016-1024.
2. Melendez-Martinez A.J., Vicario I.M., Heredia F.J. Nutritional importance of carotenoid pigment. Arch. Latinoam. Nutr. 2004, 54:149-154.
3. Harari A., Harats D., Marko D., Cohen H., Barshack I., Kamari Y., Gonen A., Gerber Y., Ben-Amotz A., Shaish A. A 9-cis beta-carotene-enriched diet inhibits atherogenesis and fatty liver formation in LDL receptor knockout mice. J. Nutr. 2008, 138:1923-1930.
4. Ofelia C.Z., Federico G.J., Ricardo M.G. Comparative study of carotenoid composition in three mexican varieties of Capsicum annuum L. Food Chem. 2005, 90:109-114.
5. Nomura T., Kikuchi M., Kubodera A., Kawakami Y. Proton-donative antioxidant activity of fucoxanthin with 1,1-diphenyl-2-picrylhydrazyl (DPPH). Biochem. Mol. Biol. Int. 1997, 42:361-370.
6. y mice. J. Agric. Food Chem. 2007, 55:7701-7706.
7. Woo M.N., Jeon S.M., Shin Y.C., Lee M.K., Kang M.A., Choi M.S. Anti-obese property of fucoxanthin is partly mediated by altering lipid-regulating enzymes and uncoupling proteins of visceral adipose tissue in mice. Mol. Nutr. Food Res. 2009, 53:1603-1611.
8. American Institute of Nutrition Report of the American Institute of Nutrition (1977) Ad hoc committee on standards for nutritional studies. J. Nutr. 1977, 107:1340-1348.
9. Allain C.C., Poon L.S., Chen C.S.G., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 1974, 20:470-475.
10. McGowan M.W., Artiss J.D., Strandbergh D.R., Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 1983, 29:538-542.
11. Folch J., Lee M., Sloan Stanley G.H. A simple method for isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-509.
12. Folch H., Eller G., Mena M., Esquivel P. Suppressive effect of high doses of phytohemagglutinin in humoral and cellular immune response. Zentralbl. Veterinarmed. B 1983, 30:203-2010.
13. Nepokroeff C.M., Lakshmanan M.R., Poter J.W. Fatty acid synthase from rat liver. Methods Enzymol. 1975, 35:37-44.
14. Walton P.A., Possmayer F. Development of an assay employing a defined chemical substrate which reflects the phosphohydrolase activity measured using membrane-bound substrate. Anal. Biochem. 1985, 151:479-486.
15. Ochoa S. Malic enzyme: mallic enzymes from pigeon and wheat germ. Methods in Enzymmology 1995, 323-326. Academic Press, New York. S.P. Colowick, N.O. Kaplan (Eds.).
16. Pitkänen E., Pitkänen O., Uotila L. Enzymatic determination of unbound D-mannose in serum. Eur. J. Clin. Chem. Clin. Biochem. 1997, 35:761-766.
17. Lazarow P.B. Assay of peroxisomal β-oxidation of fatty acids. Methods Enzymol. 1981, 72:315-319.
18. Markwell M.A., McGroarty E.J., Bieber L.L., Tolbert N.E. The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. J. Biol. Chem. 1973, 248:3426-3432.
19. Shapiro D.J., Nordstrom J.L., Mitschelen J.J., Rodwell V.W., Schimke R.T. Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. Biochim. Biophys. Acta 1974, 370:369-377.
20. Erickson S.K., Schrewsbery M.A., Brooks C., Meyer D.J. Rat liver acyl-coenzyme A: cholesterol acyltransferase: Its regulation in vivo and some of properties in vitro. J. Lipid Res. 1980, 21:930-941.
21. Bradford M.M. Arapid and sensitive method for the quantitatitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
22. -ΔΔct method. Methods 2001, 25:402-408.
23. Juhan-Vague I., Alessi M.C. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb. Haemost. 1997, 78:656-660.
24. Sheng L., Qian Z., Zheng S., Xi L. Mechanism of hypolipidemic effect of crocin in rats:crocin inhibits pancreatic lipase. Eur. J. Pharmacol. 2006, 543:116-122.
25. Nicolle C., Cardinault N., Aprikian O., Busserolles J., Grolier P., Rock E., Demigne C., Mazur A., Scalbert A., Amouroux P., Remesy C. Effect of carrot intake on cholesterol metabolism and on antioxidant status in cholesterol-fed rat. Eur. J. Nutr. 2003, 42:254-261.
26. Matsumoto M., Hosokawa M., Matsukawa N., Hagio M., Shinoki A., Nishimukai M., Miyashita K., Yajima T., Hara H. Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats. Eur. J. Nutr. 2009, [Epub ahead of print].
27. Zulet M.A., Barber A., Garcin H., Higueret P., Martínez J.A. Alterations in carbohydrate and lipid metabolism induced by a diet rich in coconut oil and cholesterol in a rat model. J. Am. Coll. Nutr. 1999, 18:36-42.
28. Raz I., Eldor R., Cernea S., Shafrir E. Diabetes, insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab. Res. Rev. 2005, 21:3-14.
29. Rao A.V., Agarwal S. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr. Cancer 1998, 31:199-203.
30. Takahashi H.I., Youko H., Shiomi T., Ayakawa Y., Miyata N. Decrease of the plasma cholesterol level by administration of Dunaliella extract in exogenous hypercholemic mice. Aicho. Ika. Daigaku. Igakkai. Zasshi. 2000, 28:249-255.
31. Tall A.R. Plasma high density lipoproteins metabolism and relationship to atherogenesis. J. Clin. Invest. 1990, 86:379-384.
32. Chang S., Graham B., Yakubu F., Lin D., Peters J.C., Hill J.O. Metabolic differences between obesity-prone and obesity-resistant rats. Am. J. Physiol. 1990, 259:R1103-R1110.
33. Ghibaudi L., Cook J., Farley C., van Heek M., Hwa J.J. Fat intake affects adiposity, comorbidity factors, energy metabolism of Sprague-Dawley rats. Obes. Res. 2002, 10:956-963.
34. Campfield L.A., Smith F.J. The pathogenesis of obesity. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 1999, 13:13-30.
35. Zhou Y.P., Grill V. Long-term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J. Clin. Endocrinol. Metab. 1995, 80:1584-1590.
36. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.P., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
37. Goldstein D.E., Little R.R., Lorenz R.A., Malone J.I., Nathan D., Peterson C.M. Tests of glycemia in diabetes. Diabetes Care 1995, 18:896-909.
38. Harding A.H., Sargeant L.A., Welch A., Oakes S., Luben R.N., Bingham S., Day N.E., Khaw K.T., Wareham N.J. Fat consumption and HbA(1c) levels: the EPIC-Norfolk stud. Diabetes Care 2001, 24:11-16.
39. Sánchez A., Rubano D.A., Shavlik G.W., Hubbard R., Horning M.C. Cholesterolemic effects of the lysine/arginine ratio in rabbits after initial early growth. Arch. Latinoam Nutr. 1988, 38:229-238.
40. Matsusue K., Haluzik M., Lambert G., Yim S.H., Gavrilova O., Ward J.M., Brewer B., Reitman M.L., Gonzalez F.J. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J. Clin. Invest. 2003, 111:737-747.
41. Yu S., Matsusue P., Kashireddy W.-Q., Cao V., Yeldandi A.V., Yeldandi M.S., Rao F.J. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma 1 (PPARgamma 1) overexpression. J. Biol. Chem. 2003, 278:498-505.
42. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W. Control of the peroxisomal [beta]-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 1992, 68:879-887.